N/A
Completed N=1,164
A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes
Source: ClinicalTrials.gov NCT03761797 ↗Enrolled (actual)
1,164
Serious AEs
3.5%
Results posted
Jan 2023
Primary outcomePrimary: Number of Participants With Adverse Drug Reactions (ADRs) — 32 Participants
Summary
Study objectives is to investigate the safety of long-term daily use of TRADIANCE® Combination Tablets AP and BP in Japanese patients with Type 2 Diabetes mellitus (T2DM) used in routine care.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Adverse Drug Reactions (ADRs) |
32 | — |
Eligibility Criteria
Inclusion Criteria
- Japanese patients with Type 2 Diabetes mellitus (T2DM) who are prescribed with TRADIANCE® Combination Tablets AP or BP
- Patients who have never been treated with TRADIANCE® Combination Tablets AP or BP before enrolment
Exclusion Criteria
None
Data sourced from ClinicalTrials.gov (NCT03761797). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.